Ramipril Capsule
Product Images NDC 51655-346

5 FDA label images from Northwind Health Company, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Ramipril (NDC 51655-346). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northwind Health Company, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula For Ramipril (32265d51 201f 404a 8762 14f10a8df969 01)

Structural Formula For Ramipril (32265d51 201f 404a 8762 14f10a8df969 01)
Chemical structure diagram of the active ingredient Ramipril. The structure includes multiple rings and functional groups typical of Ramipril's molecular composition.*
FDA Label Image

Graph1 (32265d51 201f 404a 8762 14f10a8df969 02)

Graph1 (32265d51 201f 404a 8762 14f10a8df969 02)
A line graph comparing the proportion of patients on the y-axis with days of follow-up on the x-axis up to 1600 days. It shows two lines: one labeled Ramipril (solid line) and one labeled Placebo (dashed line). The graph indicates changes in patient proportions over time for both groups, with a p-value of 0.0001 marked on the plot.*
FDA Label Image

Graph2 (32265d51 201f 404a 8762 14f10a8df969 03)

Graph2 (32265d51 201f 404a 8762 14f10a8df969 03)
A forest plot displaying the relative risk of a composite outcome for multiple patient subgroups treated with Ramipril, compared to placebo. Subgroups include overall population, those with and without cardiovascular disease, diabetes, age groups, sex, hypertension, coronary artery disease history, prior myocardial infarction, cerebrovascular disease, peripheral vascular disease, and microalbuminuria. The x-axis represents relative risk in the Ramipril group with 95% confidence intervals.*
FDA Label Image

Image (32265d51 201f 404a 8762 14f10a8df969 350 1)

FDA Label Image

Label (51655 346 26 Rev B 02 22 Nhc)

Label (51655 346 26   Rev B 02 22 Nhc)
Label for Ramipril 10 mg capsules, USP, oral dosage form. The package contains 90 capsules and is for prescription use only. The label includes storage instructions to keep at 20°-25°C (68°-77°F) and to store in the original container, away from children. The product is labeled by Northwind Health Company, LLC with NDC 51655-346.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.